covid vaccine serum institute of india

Amid Doubts About AstraZeneca Shot, South Africa Denies Wanting To Return Doses

Initial Findings on ‘Adverse Event’ Didn’t Necessitate Halting of Vaccine Trials, Says Centre

Serum Institute Insists Vaccine Candidate Is ‘Safe’, Trial Participants Are Wary